Thrivent Financial for Lutherans Reduces Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Thrivent Financial for Lutherans lowered its stake in Axon Enterprise, Inc. (NASDAQ:AXON) by 10.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 226,329 shares of the biotechnology company’s stock after selling 27,754 shares during the period. Thrivent Financial for Lutherans owned 0.30% of Axon Enterprise worth $134,556,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. Groupama Asset Managment acquired a new stake in shares of Axon Enterprise during the third quarter worth about $200,000. Massachusetts Financial Services Co. MA acquired a new stake in Axon Enterprise during the 3rd quarter valued at approximately $120,553,000. Proficio Capital Partners LLC acquired a new stake in shares of Axon Enterprise in the fourth quarter worth $78,414,000. Westfield Capital Management Co. LP increased its stake in shares of Axon Enterprise by 12.2% in the third quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock worth $469,661,000 after acquiring an additional 127,769 shares during the period. Finally, Assenagon Asset Management S.A. raised its holdings in shares of Axon Enterprise by 328.7% during the fourth quarter. Assenagon Asset Management S.A. now owns 145,299 shares of the biotechnology company’s stock worth $86,354,000 after purchasing an additional 111,405 shares during the last quarter. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Axon Enterprise Stock Down 0.3 %

Shares of NASDAQ AXON opened at $554.82 on Tuesday. Axon Enterprise, Inc. has a 52-week low of $273.52 and a 52-week high of $715.99. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The company’s 50-day simple moving average is $593.10 and its 200-day simple moving average is $538.04. The firm has a market cap of $42.51 billion, a price-to-earnings ratio of 143.36, a price-to-earnings-growth ratio of 5.17 and a beta of 1.12.

Wall Street Analysts Forecast Growth

Several research firms have commented on AXON. JMP Securities reaffirmed an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, February 4th. The Goldman Sachs Group lifted their price target on Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a research report on Monday, January 27th. Craig Hallum lowered Axon Enterprise from a “buy” rating to a “cautious” rating in a research report on Monday, March 10th. Northcoast Research lowered shares of Axon Enterprise from a “buy” rating to a “neutral” rating in a report on Wednesday, February 19th. Finally, Barclays reissued a “hold” rating on shares of Axon Enterprise in a report on Monday, March 10th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and eleven have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $604.67.

Insider Buying and Selling

In other news, insider Jeffrey C. Kunins sold 1,035 shares of the firm’s stock in a transaction that occurred on Monday, December 23rd. The stock was sold at an average price of $624.47, for a total value of $646,326.45. Following the transaction, the insider now owns 124,243 shares in the company, valued at $77,586,026.21. This trade represents a 0.83 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the business’s stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total value of $271,831.50. Following the sale, the director now owns 6,929 shares of the company’s stock, valued at $4,185,601.03. The trade was a 6.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 6.10% of the stock is currently owned by insiders.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.